Oramed Pharmaceuticals (ORMP) Other Non Operating Income (2011 - 2026)

Oramed Pharmaceuticals (ORMP) has 12 years of Other Non Operating Income data on file, last reported at -$50000.0 in Q1 2026.

• Quarterly Other Non Operating Income fell 119.31% year-over-year to -$50000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (up 434.06% YoY) and the FY2025 annual result came in at -$606000.0, down 2144.44% from the prior year.
• Other Non Operating Income grew to -$50000.0 in Q1 2026, from -$39.2 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $32.3 million in Q3 2025 to a low of -$39.2 million in Q4 2025.
• A 3-year average of $290875.0 and a median of $1.9 million in 2024 frame the typical range for Other Non Operating Income.
• Annual changes were most pronounced in 2025 — Other Non Operating Income soared 93.92% — and 2026, when it plunged 119.31%.
• Tracing ORMP's Other Non Operating Income over 3 years: stood at -$20.1 million in 2024, then sank by 94.97% to -$39.2 million in 2025, then surged by 99.87% to -$50000.0 in 2026.
• The last three Other Non Operating Income figures came in at -$50000.0 (Q1 2026), -$39.2 million (Q4 2025), and $32.3 million (Q3 2025), per Business Quant data.